Clinical Trials Logo

Clinical Trial Summary

A prospective trial comparing the accuracy of [F-18]-FCH PET/MRI to US and 99mTc-MIBI SPECT/CT for pre-operative parathyroid localization in patients with primary hyperparathyroidism


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03324893
Study type Interventional
Source University Health Network, Toronto
Contact
Status Completed
Phase N/A
Start date April 3, 2018
Completion date June 23, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04555642 - Early Diagnosis of Therapy-associated Cardiotoxicity Basing on Multi-tracer Multimodality PET/MRI
Recruiting NCT05004961 - The Performance of Multi-tracer Multimodality PET in Lymphoma
Recruiting NCT05188872 - Application of 68Ga-Pentixafor PET/CT in Primary Aldosteronism and Pre-postoperative of SAAE N/A
Recruiting NCT04983095 - Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer Phase 3
Recruiting NCT05610098 - Gene Expression Profiles in Spinal Tuberculosis.
Recruiting NCT04416165 - Comparison of FDG and FAPI in Patients With Various Types of Cancer N/A
Recruiting NCT04750772 - Positron Nuclide Labeled DOTA-FAPI PET Study in Colocrectal Cancer N/A
Recruiting NCT04831541 - 68Ga-PSMA-11 PET/CT in Patients With Various Types of Cancer Early Phase 1
Recruiting NCT06188468 - ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Solid Tumors N/A
Recruiting NCT06017973 - The Role of Imaging in the Diagnosis, Management and Prognosis of Possible Non-convulsive Status Epilepticus N/A
Recruiting NCT03830242 - Diagnostic Significance of FDG PET/CT Dynamic Imaging in Detecting Metastatic Lymph Nodes With Papillary Thyroid Cancer. N/A
Recruiting NCT06387381 - 68Ga-PSFA PET Imaging in Patients With PSMA/FAP Positive Disease Early Phase 1
Recruiting NCT05506566 - 68Ga-FAP-CHX PET/CT : Dosimetry and Preliminary Clinical Translational Studies Phase 1/Phase 2
Not yet recruiting NCT04367948 - Positron Nuclide Labeled NOTA-FAPI PET Study in Lymphoma N/A
Recruiting NCT05757804 - Study of 18F-0502B PET Imaging Targeting α-synuclein in the Diagnosis of α-synuclein-related Diseases
Completed NCT05392205 - Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer N/A
Completed NCT03741231 - 18FDG-PET in Patients With Melanoma or NSCLC Treated With Immunotherapy
Completed NCT01035164 - Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy Volunteers Phase 1
Completed NCT03107663 - ⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's Lymphoma Phase 1
Recruiting NCT03636607 - Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions of Primary Hepatocellular Carcinoma N/A